These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2507174)

  • 21. [Detection of carriers of "N. meningitidis" during recrudencence of epidemic cerebrospinal meningitis].
    Renga G; Mellino M; Caruso E
    Ig Mod; 1968; 61(5):342-58. PubMed ID: 4976602
    [No Abstract]   [Full Text] [Related]  

  • 22. [New antigenic determination of Neisseria meningitidis. I. Results of serotyping of the strains N. meningitidis isolated in CSR in the years 1976-1978 from patients with cerebrospinal meningitis and from healthy carriers (author's transl)].
    Kuzemenská P; Svandová E
    Cesk Epidemiol Mikrobiol Imunol; 1980 Dec; 29(6):360-6. PubMed ID: 6450644
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunoglobulin deficiencies and meningococcal disease.
    Castagliuolo PP; Nisini R; Quinti I; Fattorossi A; D'Amelio R
    Ann Allergy; 1986 Jul; 57(1):68-70. PubMed ID: 3729084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meningococcal carriage and immunity in western Burkina Faso, 2003.
    Yaro S; Traoré Y; Tarnagda Z; Sangaré L; NjanpopLafourcade BM; Drabo A; Findlow H; Borrow R; Nicolas P; Gessner BD; Mueller JE
    Vaccine; 2007 Sep; 25 Suppl 1():A42-6. PubMed ID: 17559988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural serum bactericidal activity against Neisseria meningitidis isolates from disseminated infections in normal and complement-deficient hosts.
    Ross SC; Berberich HM; Densen P
    J Infect Dis; 1985 Dec; 152(6):1332-5. PubMed ID: 3934293
    [No Abstract]   [Full Text] [Related]  

  • 26. Meningococcal meningitis in CSR: a preepidemic situation?
    Kuzemenska P; Kriz B; Svandova E
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):195-203. PubMed ID: 6431713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Group-specific polysaccharide antigen and humoral antibody response in disease due to Neisseria meningitidis.
    Hoffman TA; Edwards EA
    J Infect Dis; 1972 Dec; 126(6):636-44. PubMed ID: 4123779
    [No Abstract]   [Full Text] [Related]  

  • 28. [The humoral immunity indices and complement functional activity in salmonellosis during the dynamics of the disease].
    Kulikova IN; Kasimova NB; Sazhnev SV; Karpenko SF; Arshba TE; Gor'kova AI
    Ter Arkh; 1996; 68(4):75-7. PubMed ID: 9324802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions between Neisseria meningitidis and the complement system.
    Schneider MC; Exley RM; Ram S; Sim RB; Tang CM
    Trends Microbiol; 2007 May; 15(5):233-40. PubMed ID: 17398100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlation between microflora and indices of immunity in cosmonaut carriers of nasal Staphylococcus aureus during the preflight period].
    Nikolaeva TN; Guseva EV; Tashpulatov RIu; Syrykh GD
    Kosm Biol Aviakosm Med; 1982; 16(1):40-3. PubMed ID: 7062697
    [No Abstract]   [Full Text] [Related]  

  • 31. Recognition of meningococcal molecular patterns by innate immune receptors.
    Schmitt C; Villwock A; Kurzai O
    Int J Med Microbiol; 2009 Jan; 299(1):9-20. PubMed ID: 18706860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A patient with meningococcal meningitis and deficiency of the 7th factor of the complement system].
    Moolenaar W; Pott Hofstede D; Hack CE; Hannema AJ
    Ned Tijdschr Geneeskd; 1987 May; 131(20):866-8. PubMed ID: 3108681
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunoepidemiological study of the meningococcal carrier state in groups of children and adolescents].
    Deviatkina NP; Petrova IS; Uogintas GP; Konovalova OV; Rutene KL
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Jan; (1):67-71. PubMed ID: 6805174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Meningococcal meningitis with antigens common to Neisseria meningitidis and Neisseria gonorrhoeae].
    Sanchis-Bayarri Vaillant V; Donderis Torrens S; Martínez Medina MC; Sanchis-Bayarri Bernal MR
    Rev Clin Esp; 1986 Apr; 178(6):315-6. PubMed ID: 3088683
    [No Abstract]   [Full Text] [Related]  

  • 35. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
    Mueller JE; Borrow R; Gessner BD
    Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meningococcal surrogates of protection--serum bactericidal antibody activity.
    Borrow R; Balmer P; Miller E
    Vaccine; 2005 Mar; 23(17-18):2222-7. PubMed ID: 15755600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Homozygotic C5 deficiency disclosed by purulent Neisseria meningitidis meningitis].
    Cesbron JY; Maillet F; Valance J; Langlet N; Kazatchkine M
    Presse Med; 1985 Dec; 14(45):2287-9. PubMed ID: 2935813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there a genetic immune defect in families with meningococcal meningitis?
    Whittle HC; Werblinska J; Hassan-King M; Greenwood BM; Wolf E; Festenstein H; van Loghem E
    J Infect; 1981 Jun; 3(2):140-9. PubMed ID: 6821093
    [No Abstract]   [Full Text] [Related]  

  • 39. Absence of the sixth component of complement in a patient with repeated episodes of meningococcal meningitis.
    Lim D; Gewurz A; Lint TF; Ghaze M; Sepheri B; Gewurz H
    J Pediatr; 1976 Jul; 89(1):42-7. PubMed ID: 819642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The prognosis of the outcome and the correction of the treatment in bacterial meningitis by using immunological monitoring].
    Lutsik BD; Kit IE; Tokarev VP
    Ter Arkh; 1990; 62(11):19-22. PubMed ID: 2094982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.